Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114669) titled 'Clinical Study of Exosomes in the Treatment of Melasma' on Dec. 16, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Fujian Medical University Union Hospital
Condition:
Melasma
Intervention:
1565 Non-ablative Fractional Laser in conjunction with Exosomes Derived from Umbilical Cord Mesenchymal Stem Cells:Application of exosomes derived from umbilical cord mesenchymal stem cells following treatment with 1565 non-ablative fractional laser.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2024-08-28
Target Sample Size: 1565 Non-ablative Fractional La...